Valion Bio Appoints Melinda Lackey as General Counsel
Alaunos Therapeutics (TCRT) has lost Melinda Lackey, its Senior Vice President of Legal & Administration, who has joined Valion Bio, Inc. as General Counsel. During her tenure at Alaunos, Lackey managed all legal and compliance functions for the publicly traded immunology company, overseeing regulatory strategy and capital markets obligations.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.